Analyze Diet
Equine veterinary journal2015; 48(2); 152-158; doi: 10.1111/evj.12383

Intra-articular treatment with triamcinolone compared with triamcinolone with hyaluronate: A randomised open-label multicentre clinical trial in 80 lame horses.

Abstract: Intra-articular (IA) injection of corticosteroids with or without hyaluronate (HA) has been used for decades in equine practice for treatment of noninfectious synovitis and osteoarthritis. However, to date, no large-scale randomised equine field trials have been reported that address the supposed superior clinical efficacy of the combination of corticosteroid + HA compared with IA injection of corticosteroid alone. Objective: To compare the clinical efficacy of IA triamcinolone acetonide (TA, 12 mg) compared with IA TA (12 mg) + high molecular weight HA (20 mg) in horses with clinical joint disease. Methods: Prospective, randomised, parallel, open label, multicentre clinical trial. Methods: Eighty client-owned horses from 13 clinics were included. Lameness and effusion scores were assessed at baseline and 3 weeks after IA treatment. A standardised telephone questionnaire was completed between the owner and consulting veterinarian at 3 months. The primary outcome parameter was clinical success rate, defined as ≥2 grades lameness reduction (on a 0-5 scale) at 3 weeks. Chi-square statistics and binary logistic regression were used to analyse data on an intention-to-treat basis for the 3 week outcome. Results: The success rate of IA TA 3 weeks after treatment was 87.8%, while that of TA+HA was 64.1% (P = 0.01). Age >13 years was associated with a reduced success rate for the combination treatment (P = 0.004) at 3 weeks. At 3 months, half the horses in each group had returned to their previous level of performance. Conclusions: The combination of TA with HA was associated with a lower short-term clinical success rate and a similar medium-term outcome compared with IA TA, with only half of the horses performing at their previous level of exercise after 3 months regardless of treatment group allocation.
Publication Date: 2015-02-02 PubMed ID: 25377505DOI: 10.1111/evj.12383Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper assesses the effectiveness of corticosteroids alone versus corticosteroids with hyaluronate in treating joint disease in horses. The study suggests that corticosteroids alone are more effective in the short term, with half the horses reverting to their previous exercise levels after three months, regardless of the treatment combination received.

Objective and Methodology

  • The objective of the study was to compare the clinical effectiveness of intra-articular (IA) treatment using triamcinolone acetonide (TA) alone versus TA combined with hyaluronate (HA) in horses with joint disease.
  • This was a multicentre, open label clinical trial with a prospective, randomised and parallel design. Eighty horses from 13 different clinics participated.
  • After assessing the initial lameness and joint fluid swelling (effusion) scores, the horses received IA treatment. Three weeks later the assessments were repeated to evaluate the treatment’s effectiveness.
  • A standardized telephone questionnaire was also conducted three months after the treatment between the vet and the horse owner.
  • The success rate of the treatments, the primary outcome parameter, was determined by a reduction in lameness by two or more grades on a 0-5 scale, three weeks post-treatment.

Results

  • The research found that horses receiving the corticosteroid treatment alone (TA) exhibited an 87.8% success rate three weeks after injection, whereas the combination treatment of TA and HA had a 64.1% success rate.
  • The study also indicated that horses aged older than 13 years responded less effectively to the combination treatment.
  • Three months after the treatment, only 50% of the horses in each group had returned to their prior level of performance.

Conclusions

  • The findings suggest that the combination of TA and HA for IA treatment is associated with a lower short-term clinical success rate than TA alone.
  • However, the long-term results were similar for both treatments, as only half of the horses returned to their previous exercise levels after three months, regardless of the treatment received.
  • Therefore, this study highlights the need for an improved treatment approach or continued research into better treatment options for joint disease in horses.

Cite This Article

APA
de Grauw JC, Visser-Meijer MC, Lashley F, Meeus P, van Weeren PR. (2015). Intra-articular treatment with triamcinolone compared with triamcinolone with hyaluronate: A randomised open-label multicentre clinical trial in 80 lame horses. Equine Vet J, 48(2), 152-158. https://doi.org/10.1111/evj.12383

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 48
Issue: 2
Pages: 152-158

Researcher Affiliations

de Grauw, J C
  • Department of Equine Sciences, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.
Visser-Meijer, M C
  • Veterinary Center Honselersdijk, The Netherlands.
Lashley, F
  • Equine Clinic de Raaphorst, Wassenaar, The Netherlands.
Meeus, P
  • Veterinary Clinic Ridderkerk, The Netherlands.
van Weeren, P R
  • Department of Equine Sciences, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.

MeSH Terms

  • Animals
  • Horse Diseases / drug therapy
  • Horses
  • Hyaluronic Acid / administration & dosage
  • Hyaluronic Acid / therapeutic use
  • Injections, Intra-Articular
  • Joint Diseases / drug therapy
  • Joint Diseases / veterinary
  • Lameness, Animal / drug therapy
  • Risk Factors
  • Treatment Outcome
  • Triamcinolone Acetonide / administration & dosage
  • Triamcinolone Acetonide / therapeutic use

Citations

This article has been cited 9 times.
  1. Schultz RH, Hawkins JF, Hermida JA. Diagnostic imaging findings and management of osteoarthritis in pigs with image-guided intra-articular injections. Vet Surg 2025 Oct;54(7):1433-1442.
    doi: 10.1111/vsu.70002pubmed: 40873115google scholar: lookup
  2. Guidoni K, Chiaradia E, Pepe M, Di Meo A, Tognoloni A, Seccaroni M, Beccati F. The Combined Use of Triamcinolone and Platelet-Rich Plasma in Equine Metacarpophalangeal Joint Osteoarthritis Treatments: An In Vivo and In Vitro Study. Animals (Basel) 2024 Dec 17;14(24).
    doi: 10.3390/ani14243645pubmed: 39765549google scholar: lookup
  3. Serpieri M, Bonaffini G, Ottino C, Quaranta G, Manassero L, Mauthe VON Degerfeld M. Conservative treatment of a synovial cyst in a golden eagle (Aquila chrysaetos) with triamcinolone acetonide. J Vet Med Sci 2024 May 25;86(5):592-595.
    doi: 10.1292/jvms.23-0474pubmed: 38616122google scholar: lookup
  4. Holmes TQ, Brown AF. Champing at the Bit for Improvements: A Review of Equine Welfare in Equestrian Sports in the United Kingdom. Animals (Basel) 2022 May 5;12(9).
    doi: 10.3390/ani12091186pubmed: 35565612google scholar: lookup
  5. Ribitsch I, Oreff GL, Jenner F. Regenerative Medicine for Equine Musculoskeletal Diseases. Animals (Basel) 2021 Jan 19;11(1).
    doi: 10.3390/ani11010234pubmed: 33477808google scholar: lookup
  6. Sullivan SN, Altmann NN, Brokken MT, Durgam SS. In vitro Effects of Methylprednisolone Acetate on Equine Deep Digital Flexor Tendon-Derived Cells. Front Vet Sci 2020;7:486.
    doi: 10.3389/fvets.2020.00486pubmed: 32851046google scholar: lookup
  7. Ekstrand C, Bondesson U, Giving E, Hedeland M, Ingvast-Larsson C, Jacobsen S, Löfgren M, Moen L, Rhodin M, Saetra T, Ranheim B. Disposition and effect of intra-articularly administered dexamethasone on lipopolysaccharide induced equine synovitis. Acta Vet Scand 2019 Jun 20;61(1):28.
    doi: 10.1186/s13028-019-0464-2pubmed: 31221173google scholar: lookup
  8. Held F, Ekstrand C, Cvijovic M, Gabrielsson J, Jirstrand M. Modelling of oscillatory cortisol response in horses using a Bayesian population approach for evaluation of dexamethasone suppression test protocols. J Pharmacokinet Pharmacodyn 2019 Feb;46(1):75-87.
    doi: 10.1007/s10928-018-09617-0pubmed: 30673914google scholar: lookup
  9. Broeckx SY, Seys B, Suls M, Vandenberghe A, Mariën T, Adriaensen E, Declercq J, Van Hecke L, Braun G, Hellmann K, Spaas JH. Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses. Stem Cells Dev 2019 Mar 15;28(6):410-422.
    doi: 10.1089/scd.2018.0061pubmed: 30623737google scholar: lookup